Odessa-Maud Fayet

Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis

E. Fadel, S. Berrih-Aknin, F. Truffault, 2021, Journal of neuroinflammation.

Decreased expression of miR-29 family associated with autoimmune myasthenia gravis

E. Fadel, A. Liston, S. Berrih-Aknin, 2020, Journal of neuroinflammation.

Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.

D. Gossot, E. Fadel, P. Validire, 2019, Journal of autoimmunity.

Myasthenia Gravis: An Acquired Interferonopathy?

Nadine Dragin, S. Berrih-Aknin, R. Le Panse, 2022, Cells.

Single-cell mass cytometry on peripheral cells in Myasthenia Gravis identifies dysregulation of innate immune cells

S. Demeret, E. Fadel, A. Béhin, 2023, Frontiers in Immunology.

Central Role of Macrophages and Nucleic Acid Release in Myasthenia Gravis Thymus

S. Demeret, E. Fadel, D. Duffy, 2022, Annals of neurology.

Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis

E. Fadel, S. Berrih-Aknin, F. Truffault, 2021, Journal of neuroinflammation.